UFP Technologies, Inc. (UFP.F)
- Previous Close
218.60 - Open
220.60 - Bid 215.60 x --
- Ask 220.00 x --
- Day's Range
220.60 - 220.60 - 52 Week Range
161.00 - 321.20 - Volume
47 - Avg. Volume
3 - Market Cap (intraday)
1.737B - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
30.05 - EPS (TTM)
7.34 - Earnings Date Jul 29, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company offers protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and custom protective case systems for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. The company serves the medical, aerospace and defense, industrial, and automotive markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
www.ufpt.comRecent News: UFP.F
View MorePerformance Overview: UFP.F
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UFP.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UFP.F
View MoreValuation Measures
Market Cap
1.72B
Enterprise Value
1.89B
Trailing P/E
29.76
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.45
Price/Book (mrq)
5.18
Enterprise Value/Revenue
3.82
Enterprise Value/EBITDA
20.03
Financial Highlights
Profitability and Income Statement
Profit Margin
11.59%
Return on Assets (ttm)
10.92%
Return on Equity (ttm)
19.36%
Revenue (ttm)
547.56M
Net Income Avi to Common (ttm)
63.47M
Diluted EPS (ttm)
7.34
Balance Sheet and Cash Flow
Total Cash (mrq)
14.03M
Total Debt/Equity (mrq)
55.05%
Levered Free Cash Flow (ttm)
29.66M